second paragraph of the report,
"In this period, Admedus made significant progress getting CardioCel® into cardiothoracic surgery centres across Europe and the US. By the end of the current period, 23 European centres and 20 centres in the US had used the product. These numbers have since risen further to 27 centres in Europe and 25 centres in the US, with over 1,000 patients implanted with CardioCel®."
increase of 9 from 43 to 52 is an increase of 20.93%
- Forums
- ASX - By Stock
- AVR
- good bad or indifferent
good bad or indifferent, page-27
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.90 |
Change
-0.100(0.56%) |
Mkt cap ! $341.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $49.26K | 2.755K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 34 | $17.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.91 | 32 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34 | 17.900 |
1 | 14 | 17.800 |
1 | 26 | 17.740 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
Price($) | Vol. | No. |
---|---|---|
17.910 | 32 | 2 |
17.930 | 38 | 2 |
17.950 | 271 | 3 |
18.000 | 518 | 2 |
18.250 | 100 | 1 |
Last trade - 14.46pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online